Dexterra Group Inc (DXT.TO)
6.09
-0.05
(-0.81%)
CAD |
TSX |
Nov 04, 12:26
Dexterra Group Revenue (Quarterly): 253.62M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 253.62M |
March 31, 2024 | 231.64M |
December 31, 2023 | 270.53M |
September 30, 2023 | 310.75M |
June 30, 2023 | 214.71M |
March 31, 2023 | 216.03M |
December 31, 2022 | 253.86M |
September 30, 2022 | 259.80M |
June 30, 2022 | 233.90M |
March 31, 2022 | 223.96M |
December 31, 2021 | 201.59M |
Date | Value |
---|---|
September 30, 2021 | 202.76M |
June 30, 2021 | 173.63M |
March 31, 2021 | 155.40M |
December 31, 2020 | 164.42M |
September 30, 2020 | 176.92M |
June 30, 2020 | 76.11M |
March 31, 2020 | 60.37M |
December 31, 2019 | 64.13M |
September 30, 2019 | 76.15M |
June 30, 2019 | 66.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
60.37M
Minimum
Mar 2020
310.75M
Maximum
Sep 2023
197.06M
Average
214.71M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
Mullen Group Ltd | 532.04M |
Doman Building Materials Group Ltd | 689.83M |
Exchange Income Corp | 660.58M |
Bactech Environmental Corp | -- |
Beyond Medical Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 8.978M |
Total Expenses (Quarterly) | 233.87M |
EPS Diluted (Quarterly) | 0.14 |
Enterprise Value | 533.04M |
Gross Profit Margin (Quarterly) | 16.52% |
Profit Margin (Quarterly) | 3.54% |
Earnings Yield | 4.76% |
Operating Earnings Yield | 14.34% |
Normalized Earnings Yield | 8.247 |